Clinical Advisory Board

Aftab Ala - Wilson Disease Clinical Advisory Board

Aftab Ala, MBBS, MD, Ph.D., FRCP

Education and other assignments: Professor Ala is an experienced Consultant in Gastroenterology and Hepatology at The Royal Surrey County Hospital NHS Foundation, UK. He graduated from Charing Cross and Westminster Hospitals in 1992 and completed postgraduate studies at King’s College Hospital, UK. He underwent Gastroenterology and Hepatology training at King’s College and Royal Free Hospital, followed by an Advanced Liver Fellowship at Mount Sinai Hospital focused on liver and bowel diseases. His Ph.D. from University College London focused on immune and inflammatory mechanisms in gut and liver disease.

Professor Ala is the South East Coast England NIHR Lead for liver disease, member of the NICE Team in developing the 2013 Guidelines Hepatitis B management, NHS England Hepatitis C Advisory Group, regional Clinical Reference Group (CRG) representative for liver, bile duct and pancreatic disease. His research interests in the Department of Clinical and Experimental Medicine at University of Surrey include inherited/metabolic liver diseases, Wilson disease, and community and outreach programmes.

Fred Askari - Wilson Disease Clinical Advisory Board

Fred Askari, MD, Ph.D.

Education and other assignments: Fred Askari completed his undergraduate education at Cornell University in Ithaca, NY, then earned his MD and Ph.D. in Pharmacology at Cornell University Medical College in NY, NY. He completed his clinical training in Internal Medicine, Medical Genetics and Gastroenterology/Hepatology at the University of Michigan, while concluding post doctoral research training at the Howard Hughes Medical Institute at the University of Michigan in Ann Arbor, Michigan. He directs the Wilson Disease Program at the University of Michigan.

Anna Czlonkowska - Wilson Disease Clinical Advisory Board

Anna Czlonkowska, MD, Prof

Education and other assignments: Anna Czlonkowska, MD, Prof, earned her Diploma of Medicine at Warsaw Medical Academy before she completed her Doctor of Medicine at the Institute of Psychiatry and Neurology, Warsaw. She received additional training at the Boards of Clinical Neurology at the Institute of Psychiatry and Neurology in Warsaw and Habilitation in Neurology at the Warsaw Medical Academy. She has also received several fellowships, ranging from the British Council Grant for Neuroimmunology and the Neurobiology Fellow via Max Planck Society Grant. Between 1985-2013, she served as a professor and the Head of the Second Department of Neurology and is currently the professor in this department and the Head of the Study Group at the Department of Experimental and Clinical Pharmacology, Medical University of Warsaw. Additionally, Czlonkowska served as a member of the International Consortium at EUROWILSON. Since 1969, Czlonkowska has cared for 800 patients with Wilson Disease and established a database. She cooperates with WD centers across Europe and has evaluated the clinical course of WD (with a focus on the efficacy of current therapies). She has also completed basic research for the evaluation of pathogenesis of WD.

Karl Heinz Weiss - Wilson Disease Clinical Advisory Board

Karl Heinz Weiss, MD

Education and other assignments: Karl Heinz Weiss, MD, earned his Diploma of Medicine at the University of Freiburg, where he also worked with experimental research in neuroanatomy. He completed a fellowship at the Department of Gastroenterology at the University of Heidelberg before consulting in gastroenterology at Facharzt. In 2013, he became an associate professor for Internal Medicine, senior physician, chairman of the Liver Cancer Board and the Deputy Head of Transplant Hepatology. Since 2015, he is serving as a professor at the University of Heidelberg. Weiss has published several articles within Wilson Disease.

Michael Schilsky - Wilson Disease Clinical Advisory Board

Michael Schilsky, MD, FAASLD

Education and other assignments: Michael Schilsky is an Associate Professor at the Yale School of Medicine. He is the fellowship director for Transplant Hepatology and director of the Wilson’s Disease Association designated Center of Excellence for Wilson disease at Yale. He received his medical degree from the University of Chicago and completed his residency, fellowship and post-doctoral research at Albert Einstein College of Medicine and Montefiore Medical Center. He became a faculty member of the Division of Gastroenterology and member of the Liver Research Center at Einstein where he directed laboratory work on copper metabolism. In 1999, he served as director of the Liver Medicine Clinic and led a Wilson Disease clinic at Mount Sinai. In 2007, he joined the Center for Liver Disease and Transplantation at the New York Weill Cornell Medical Center where he developed a program for liver transplant and Wilson Disease patients.

Dr. Schilsky coauthored the AASLD and EASL practice guidelines for Wilson disease and authored numerous original manuscripts, chapters and reviews on Wilson disease. He is a member of the NIH Sponsored Acute Liver Failure Study Group.